
Redefining Bioconjugation and the Future of ADCs with Dr. Abbas Sahili of Singzyme
Nucleate Singapore Pulse ›36:07 | May 16th
Dr. Abbas Sahili is the Co-founder and CEO of Singzyme, a biotechnology company pioneering next-generation bioconjugation technologies. With a strong background in biochemistry and structural biology,...Show More
Recommendations